abstract |
The present invention is generally directed to pharmaceutical compositions, methods, and kits for improving the side effects associated with treatment with an aromatase inhibitor in a subject diagnosed with breast cancer. More specifically, the present invention provides compositions, methods, and kits comprising an aromatase inhibitor and an androgenic agent. [Selection figure] None |